Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Shashwat Goenka takes over as Vice President of industry body
Subscribe To Our Newsletter & Stay Updated